Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
出版年份 2018 全文链接
标题
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
作者
关键词
Liposarcoma, Patient-derived orthotopic xenograft, PDOX, PDGFRA amplification, Trabectedin, Precision medicine
出版物
BMC CANCER
Volume 18, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-20
DOI
10.1186/s12885-018-4703-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models
- (2018) Kentaro Igarashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Apatinib for advanced sarcoma: results from multiple institutions’ off-label use in China
- (2018) Lu Xie et al. BMC CANCER
- Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma
- (2018) Filippo Spriano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma
- (2018) Kentaro Igarashi et al. CANCER LETTERS
- Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy
- (2018) Kentaro Igarashi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model
- (2018) Tasuku Kiyuna et al. TISSUE & CELL
- MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model
- (2018) Kei Kawaguchi et al. TISSUE & CELL
- Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
- (2017) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer
- (2017) Jean-Philippe Adam et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
- (2017) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
- (2017) Kentaro Igarashi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
- (2017) Kei Kawaguchi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
- (2017) Audrey Laroche et al. Journal of Hematology & Oncology
- PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
- (2017) Ymera Pignochino et al. Molecular Cancer
- Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies
- (2017) Mitsuru Takahashi et al. ONCOLOGIST
- Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
- (2017) Kentaro Igarashi et al. Oncotarget
- A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
- (2017) Kentaro Igarashi et al. Oncotarget
- Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
- (2017) Takaaki Nakai et al. Cancer Medicine
- Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
- (2017) Yevette McGovern et al. Frontiers in Oncology
- Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study
- (2016) Fernando A. Angarita et al. BMC CANCER
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-derived xenografts: a relevant preclinical model for drug development
- (2016) Luca Pompili et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model
- (2016) Mako Yamamoto et al. PLoS One
- Liposarcoma
- (2016) Aimee M. Crago et al. Surgical Oncology Clinics of North America
- Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model
- (2016) Takashi Murakami et al. Oncotarget
- High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model
- (2016) Tasuku Kiyuna et al. Oncotarget
- The value of trabectedin in the treatment of soft tissue sarcoma
- (2016) Tomoki Nakamura et al. Therapeutics and Clinical Risk Management
- Managing Liposarcomas: Cutting Through the Fat
- (2016) Gulam A. Manji et al. Journal of Oncology Practice
- Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
- (2015) J. Khalifa et al. BMC CANCER
- BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
- (2015) A Laroche-Clary et al. BRITISH JOURNAL OF CANCER
- Unique features of trabectedin mechanism of action
- (2015) Annette K. Larsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial
- (2015) B. Bui-Nguyen et al. EUROPEAN JOURNAL OF CANCER
- Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern
- (2015) Yukihiko Hiroshima et al. PLoS One
- Advances in the targeted therapy of liposarcoma
- (2015) Guan et al. OncoTargets and Therapy
- Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
- (2015) Rita De Sanctis et al. Drug Design Development and Therapy
- Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models
- (2015) Yukihiko Hiroshima et al. Oncotarget
- Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-CEA Antibody and a Portable Imaging System
- (2014) Yukihiko Hiroshima et al. Journal of Laparoendoscopic & Advanced Surgical Techniques
- Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer
- (2014) Yukihiko Hiroshima et al. JOURNAL OF SURGICAL ONCOLOGY
- Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore
- (2014) Yukihiko Hiroshima et al. PLoS One
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model
- (2013) Cristina A. Metildi et al. JOURNAL OF SURGICAL ONCOLOGY
- Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
- (2013) William Tseng et al. Cancers
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma
- (2011) Antoine Italiano et al. CANCER
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- Systemic Management Strategies for Metastatic Soft Tissue Sarcoma
- (2011) Sujana Movva et al. DRUGS
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Orbital Pleomorphic Liposarcoma in an Eight-Year-Old Boy
- (2011) Erin Rudzinski et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- Radiological-pathological correlation of pleomorphic liposarcoma of the anterior mediastinum in a 17-year-old girl
- (2010) Maysa Saeed et al. PEDIATRIC RADIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now